Reference values for inspiratory capacity in healthy nonsmokers over age 50 years;Valores de referencia de la capacidad inspiratoria en sujetos sanos no fumadores mayores de 50 años

Archivos de Bronconeumologia

Volumn 43, Issue 9, 2007, Pages 485-489

  Lisboa, Carmen ^a   Leiva, Alicia ^a   Pinochet, Ramón ^a   Repetto, Paula ^a   Borzone, Gisella ^a   Díaz, Orlando ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Inspiratory capacity; Reference values; Slow vital capacity

Indexed keywords

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DYSPNEA; EXERCISE; FEMALE; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG FUNCTION; MALE; MATHEMATICAL MODEL; MEASUREMENT; NORMAL HUMAN; PREDICTION; REFERENCE VALUE; REGRESSION ANALYSIS; RESIDUAL VOLUME; SEX DIFFERENCE; SMOKING; SPIROMETRY; STATISTICAL ANALYSIS; VITAL CAPACITY;

EID: 36048971074     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13109468     Document Type: Article

References (26)

1. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis. 1993;148:1351-7.
2. O'Donnell DE, Lam M, Webb KA. Measurements of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1557-65.
3. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise tolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770-7.
4. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. 1980;49:511-5.
5. Díaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emili J, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J. 2000;16:269-75.
6. Marín JM, Carrizo SJ, Gascón M, Sánchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1395-9.
7. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:967-75.
8. Manríquez J, Díaz O, Borzone G, Lisboa C. Reversibilidad espirométrica en la enfermedad pulmonar obstructiva crónica: efecto diferencial del salbutamol sobre el volumen espiratorio forzado del primer segundo y del volumen pulmonar. Rev Med Chile. 2004;132:787-93.
9. Celli B, Zu Wallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124: 1743-8.
10. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163: 892-8.
11. Marín JA. Viejos y nuevos criterios para clasificar la EPOC. Arch Bronconeumol. 2004;40 Supl 6:9-15.
12. Casanova C, Cote C, De Torres JP, Aguirre-Jaime A, Marín JM, Pinto-Plata V. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:591-7.
13. Roca J, Burgos F, Barberá JA, Sunyer J, Rodríguez Roisin R, Castellsague J, et al. Prediction equations for plethysmographic lung volumes. Respir Med. 1998;92:454-60.
14. Tantucci C, Pinelli V, Cossi S, Guerini M, Donato F, Grassi V. The SARA Study Group. Reference values and repeatability of inspiratory capacity for men and women aged 65-85 yrs. Respir Med. 2006;100:871-7.
15. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced expiratory flows. Report of the working party: standardization of lung function tests. European Community for Steel and Coal. Eur Respir J. 1993;6 Suppl 16:5-40.
16. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-38.
17. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725-34.
18. Azen R, Budescu DV. The dominance analysis approach for comparing predictors in multiple regression. Psychol Methods. 2003;8:129-48.
19. Diaconis P, Efron B. Computer-intensive methods in statistics. Scientific American. 1983;248:116-30.
20. Lee WC, Rodgers JL. Bootstrapping correlation coefficients using univariate and bivariate sampling. Psychol Methods. 1998;3:91-103.
21. Harik-Khan R, Fleg JL, Muller DC, Wise RA. The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med. 2001;164:1647-54.
22. Pistelli F, Bottai M, Viegi G, Di Pede F, Carrozi L, Baldacci S, et al. Smooth reference equations for slow vital capacity and flow-volume curve indexes. Am J Respir Crit Care Med. 2000;161:899-905.
23. Instituto Nacional de Estadísticas de Chile. Censo poblacional y de vivienda 2002. Disponible en: www.ine.cl/cd2002/index.php
24. Pérez-Padilla R, Valdivia G, Muiño A, López MV, Márquez MN, Montes de Oca M, et al. Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad. Arch Bronconeumol. 2006;42:317-25.
25. Enright PL, Jonhson LR, Connett JE, Voelker H, Buist AS. Spirometry in the lung health study. Am Rev Respir Dis. 1991;143:1215-23.
26. Crapo RO. Spirometry: quality control and reproducibility criteria. Am Rev Respir Dis. 1991;143:1212-3.